Sodium valproate, hyperandrogenism and altered ovarian function in Indian women with epilepsy: A prospective study

Epilepsia

Volumn 48, Issue 7, 2007, Pages 1371-1377

  Prabhakar, Sudesh ^a   Sahota, Preeti ^a   Kharbanda, Parampreet Singh ^a   Siali, Ravinder ^a   Jain, Vanita ^a   Lal, Vivek ^a   Khurana, Dheeraj ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Drug induced reproductive abnormalities; Epilepsy; Menstrual disorders; Polycystic ovarian syndrome; Valproate

Indexed keywords

ANDROSTANOLONE; FOLLITROPIN; HORMONE; LAMOTRIGINE; LUTEINIZING HORMONE; PRASTERONE SULFATE; PROLACTIN; TESTOSTERONE; THYROTROPIN; THYROXINE; VALPROIC ACID;

ADD ON THERAPY; ADOLESCENT; ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; FOLLITROPIN BLOOD LEVEL; FOLLOW UP; GENERALIZED EPILEPSY; HIRSUTISM; HORMONE BLOOD LEVEL; HUMAN; HYPERANDROGENISM; HYPOTHYROIDISM; INDIAN; LUTEINIZING HORMONE BLOOD LEVEL; MENSTRUAL IRREGULARITY; MENSTRUATION; MENSTRUATION DISORDER; OBESITY; OLIGOMENORRHEA; OVARY DISEASE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SIDE EFFECT; TESTOSTERONE BLOOD LEVEL; WEIGHT CHANGE; WEIGHT GAIN;

BODY MASS INDEX; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; HIRSUTISM; HUMANS; HYPERANDROGENISM; INDIANS, NORTH AMERICAN; LONGITUDINAL STUDIES; LUTEINIZING HORMONE; MENSTRUATION DISTURBANCES; POLYCYSTIC OVARY SYNDROME; PROSPECTIVE STUDIES; TESTOSTERONE; VALPROIC ACID; WEIGHT GAIN;

EID: 34447331411     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2007.01100.x     Document Type: Article

References (40)

1. Bauer J, Jarre A, Klingmuller D, Elger CE 2000) Polycystic ovarian syndrome in patients with focal epilepsy: a study in 93 women. Epilepsy Research 41 (2 163 167.
2. Bilo L, Meo R, Nappi C, Annunziato L, Striano S, Colao AM, Merola B, Buscaino GA 1988) Reproductive endocrine disorders in women with primary generalized epilepsy. Epilepsia 29 (5 612 619.
3. Bilo L, Meo R, Valentino R, Di Carlo C, Striano S, Nappi C 2001) Characterization of the reproductive endocrine disorders in women with epilepsy. Journal of Clinical Endocrinological Metabolism 86 (7 2950 2956.
4. Breum L, Astrup A, Gram L, Andersen T, Stokholm KH, Christensen NJ, Werdelin L, Madsen J 1992) Metabolic changes during treatment with valproate in humans: implications for untoward weight gain. Metabolism 41 : 666 670.
5. Corman CL, Leung NM, Guberman AH 1997) Weight gain in epileptic patients during treatment with valproic acid: a retrospective study. Canadian Journal of Neurological Science 24 (3 240 244.
6. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianatelli TC, Spina GG, Zapanti ED, Bartzis MI 1999) A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. Journal of Clinical Endocrinological Metabolism 84 : 4006 4011.
7. Dinesen H, Gram L, Anderson T, Dam M 1984) Weight gain during treatment with valproate. Acta Neurologica Scandanavica 70 : 65 69.
8. Dunaif A, Thomas A 2001) Current concepts in the polycystic ovarian syndrome. Annual Review of Medicine 52 : 401 419
9. Ferriman D, Gallwey JD 1961) Clinical assessment of body growth in women. Journal of Clinical Endocrinological Metabolism 21 : 1440 1447.
10. Gidal BE, Anderson GD, Spencer NW, Maly MM, Murty J, Pitterle ME, Collins DM, Davis LA 1996) Valproate-associated weight gain: potential relation to energy expenditure and metabolism in patients with epilepsy. Journal of Epilepsy 9 : 234 241.
11. Herzog AG 1996) Polycystic ovarian syndrome in women with epilepsy: epileptic or iatrogenic? Annals of Neurology 39 : 559 560.
12. Herzog AG, Seibel MM, Schomer DL, Vaitukaitis JL, Geschwind N 1986) Reproductive endocrine disorders in women with partial seizures of temporal lobe origin. Archives of Neurology 43 : 341 346.
13. Hopkinson ZE, Sattar N, Fleming R, Greer IA 1998) Polycystic ovarian syndrome: the metabolic syndrome comes to gynecology. British Medical Journal 317 : 329 332
14. Hsueh AJ, Adashi EY, Jones PB, Welsh TH Jr. 1984) Hormonal regulation of the differentiation of cultured ovarian granulosa cells. Endocrinological Review 5 : 76 127.
15. Isojärvi JIT, Laatikainen TJ, Knip M, Pakarinen AJ, Juntunen KT, Myllylä VV 1996) Obesity and endocrine disorders in women taking valproate for epilepsy. Annals of Neurology 39 (5 579 584.
16. Isojärvi JIT, Laatikainen TJ, Pakarinen AJ, Juntunen KT, Myllylä W 1993) Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. New England Journal of Medicine 329 : 1383 1388.
17. Isojärvi JIT, Rätty J, Myllylä VV, Knip M, Koivunen R, Pakarinen AJ, Tekay A, Tapanainen JS 1998) Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy. Annals of Neurology 43 (4 446 451.
18. Isojärvi JIT, Tauboll E, Pakarinen AJ, van Parys J, Rattya J, Harbo HF, Dale PO, Fauser BC, Gjerstad L, Koivunen R, Knip M, Tapanainen JS 2001) Altered ovarian function and cardiovascular risk factors in valproate-treated women. American Journal of Medicine 111 (4 290 296.
19. Kiddy DS, Sharp PS, White DM, Scanlon MF, Mason HD, Bray CS, Polson DW, Reed MJ, Frank S 1990) Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases. Clinical Endocrinology (Oxf) 32 (2 213 230.
20. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R 1998) Prevalence of the polycystic ovary syndrome in unselected black and white women of the south-Eastern United States: a prospective study. Journal of Clinical and Endocrinological Metabolism 83 : 3078 3082.
21. Lobo RA, Carmina E 2000) The importance of diagnosing the polycystic ovarian syndrome. Annals of Internal Medicine 132 : 989 993.
22. Lofgren E, Mikkonen K, Tolonen U, Pakarinen A, Koivunen R, Myllyla VV, Tapanainen JS, Isojarvi JI 2006) Reproductive endocrine function in women with epilepsy: The role of epilepsy type and medication. Epilepsy and Behaviour Nov 10 [Epub ahead of print].
23. Loscher W 1999) Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action. Progress in Neurobiology 58 : 31 59.
24. McIntyre RS, Mancini DA, McCann S, Srinivasan J, Kennedy SH 2003) Valproate, bipolar disorder and polycystic ovarian syndrome. Bipolar Disorders 5 : 28 35.
25. Meirow D, Raz I, Yossepowitch O, Brezenski A, Rosler A, Schenker JG, Berry EM 1996) dyslipidemia in polycystic ovarian syndrome: different groups, different etiologies? Human Reproduction 11 : 1848 1853.
26. Mikkonen K, Vainionpaa LK, Pakarinen AJ, Knip M, Jarvela IY, Tapanainen JS, Isojarvi JIT 2004) Long-term reproductive endocrine health in young women with epilepsy during puberty. Neurology 62 : 445 450.
27. Morrell MJ 1999) Epilepsy in women: the science of why it is special. Neurology 53 (S3 S42 S48.
28. Mosche SL 2000) Mechanisms of action of anticonvulsant agents. Neurology 55 : S32 S40.
29. Pope HG Jr., McElroy SL, Keck PE Jr., Hudson JI 1991) Valproate in the treatment of acute mania. A placebo-controlled study. Archives of General Psychiatry 48 : 62 68.
30. O'Donovan C, Kuzumaker V, Graves GR, Bird DC 2002) Menstrual abnormalities and polycystic ovarian syndrome in women taking valproate for bipolar mood disorder. Journal of Clinical Psychiatry 63 : 322 330.
31. Proposal for revised classification of epilepsies and epileptic syndromes from the Commission on Classification and Terminology of the International League Against Epilepsy 1989) Epilepsia 30 (4 389 399.
32. Rasgon NL, Altshuler LL, Gudeman D, Burt VK, Tanavoli S, Hendrick V, Korenman S 2000) Medication status and polycystic ovarian syndrome in women with bipolar disorder: a preliminary report. Journal of Clinical Psychiatry 61 (3 173 178.
33. Rasgon NL, Reynolds MF, Elman S, Saad M, Frye MA, Bauer M, Altshuler LL 2005) Longitudinal evaluation of reproductive function in women treated for bipolar disorder. Journal of Affective Disorders 89 : 217 225.
34. Rättyä J, Pakarinen AJ, Knip M, Repo-Outakoski M, Myllylä VV, Isojärvi JIT 2001) Early hormonal changes during valproate or carbamezapine treatment: a 3-month study. Neurology 57 : 440 444.
35. Swanson M, Sauerbrei EE, Cooperberg PL 1981) Medical implications of ultrasonographically detected polycystic ovaries. Journal of Clinical Ultrasound 9 : 219 212.
36. Tanner JM 1962) Growth at adoloscence. 2nd ed, Blackwell, Oxford.
37. Vainionpǎǎ LK, Rättya J, Knip M, Tapanainen JS, Pakarinen AJ, Lanning P, Tekay A, Myllylä VV, Isojarvi JIT 1999) Valproate-induced hyperandrogenism during pubertal maturation in girls with epilepsy. Annals of Neurology 45 (4 444 450.
38. Webber MP, Hauser WA, Ottman R, Annegers JF 1986) Fertility in persons with epilepsy: 1935-1974. Epilepsia 27 : 746 752.
39. W.H.O. special programme of Research, Development and Research training in Human Reproduction, 7 ed. 1983.
40. Zawadski JK, Dunaif A 1992) Diagnostic criteria for PCOS: towards a rational approach. In Dunaif A, Givens JR, Haseltine FP, Merriam GR Eds). Polycystic Ovary syndrome. Current Issues in Endocrinology and Metabolism. Blackwell Scientific, Oxford, pp. 377 384.